Answers are grounded in this paper and cite their sources.
People with human immunodeficiency virus (HIV; hereafter, PWH) face differences in cancer treatment and quality. In a cross-sectional survey (December 2022-August 2025) of 120 PWH diagnosed with cancer and receiving care at an NCI-designated comprehensive cancer center in Florida, we examined associations of HIV stigma (Berger HIV Stigma Scale) and everyday discrimination (Everyday Discrimination Scale) with cancer care quality (Consumer Assessment of Healthcare Providers and Systems [CAHPS], Patient-Centered Communication in Cancer Care [PCCC], Health Care System Distrust, and Barriers to Care scales). Multivariable linear regression models were adjusted for sociodemographic characteristics and cancer type. Personalized stigma was associated with lower PCCC fostering healthy relationships (β: -0.29; 95% CI: -0.56, -0.01). Disclosure concerns were associated with worse care coordination (β: -0.23; 95% CI: -0.46, -0.01), greater distrust (β: 0.23; 95% CI: 0.05, 0.41), and greater barriers to care (β: 0.19; 95% CI: 0.01, 0.38). Everyday discrimination was associated with lower global healthcare ratings (β: -0.41; 95% CI: -0.71, -0.11). This is the first quantitative evidence that HIV stigma, particularly disclosure-related facets, undermined measurable cancer care quality.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: